{"name":"Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.","slug":"zogenix-international-limited-inc-a-subsidiary-of-zogenix-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi5AFBVV95cUxON0xBaTd2MmVCVjJEVDBid2VGc1VaeW1mcVB6a0wweGpGMnowWlFGVDJOaWdGZG04X2h3VU5HbUtuMjdUMWowbVQzdzh2TWNVSm5kWk1GVjJLbk1pa1U4VTk1RTVENm5fcWJrUmlqSm40ck02RlZCNTZJdmpUMUZrdG5jTmdfTzJ6NGFrS194TTNUZmNib2pmVkczVWFJc2NoQWthNE1NYU9JVkdfSmlueW56bHo2ZVJqQ1d2WjJjZHVnUklvemF0RWFOTmQxMVR1SzA1djlEeWxaVXhUY2psV0FqZ2Y?oc=5","date":"2022-09-30","type":"patent","source":"IPWatchdog.com","summary":"Patent Filings Roundup: Beer Bong Companies Clash; Crypto Company Sues Coinbase; Campaigns Spiral in Otherwise Quiet Week - IPWatchdog.com","headline":"Patent Filings Roundup: Beer Bong Companies Clash; Crypto Company Sues Coinbase; Campaigns Spiral in Otherwise Quiet Wee","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxQREZldGE4bVAwVUt3MFByeWYtOG1UekNZdmJONUEzWTkwR21sdE9LZmw4aGtQV2d2a3hsd01wWGZ5SXJmTGZCQTRCYWwyS09zcWNtUmZvNWMtZEwyTEZla1BUaFZ6blFZUHppeDRET0otMXpaWHVWZGNxalRVUXREclA4NjZKMjhUY3M2TlY4RlVWeUJXTkppV3FBZmo?oc=5","date":"2022-03-07","type":"pipeline","source":"PR Newswire","summary":"UCB Completes Acquisition of Zogenix, Inc. - PR Newswire","headline":"UCB Completes Acquisition of Zogenix, Inc.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxPeExDUE9jN1g5UW5nUVhTWlF6Qzk3Qy15SGVOc1hISVk3aURKN2J2VWdJX1VDSVNlTk01N3NrRk5RWlZNYzBtLU9zRTVUVHlUZnBtaFYxa1RQUm4zQWxrWHBOLWFvc3AyenluOFV4VVRzbjcyMnVSa3NFVnk3MGlxRkFwYW90RTcyRXZFcF9fUXRvNHNScHUxeld2NFhJekhhZzI0dGpGRy1CajVyOTlSaUxwSEtUTDJwNDdjWkdDZ21lVlpF?oc=5","date":"2022-02-01","type":"deal","source":"Fierce Pharma","summary":"How did UCB close its $1.9B deal to buy Zogenix and its key epilepsy drug? SEC filing reveals details - Fierce Pharma","headline":"How did UCB close its $1.9B deal to buy Zogenix and its key epilepsy drug? SEC filing reveals details","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxNNmJUR2VHYkNPWWhvdmN5Yzk2dDVSVHlaYkVQbTlvZkJ0Y1REWHJoaXVVcnI0ampGaXpPWDN3Yy1nSWxCdnVUcjR6cUFSOWdHQlVEOGNueTJFQk1DWjdrWjNzOEYtbllHbUZxUnFwVjdKOERmb05nZmd1bHNnMDRxbEMzWnZkRDQ2VlZvUGdVQ1J4V3lfZzJv?oc=5","date":"2022-01-20","type":"deal","source":"Pharmaceutical Technology","summary":"UCB to buy rare disease therapies developer Zogenix for $1.9bn - Pharmaceutical Technology","headline":"UCB to buy rare disease therapies developer Zogenix for $1.9bn","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxOOTdwMEpWQ0l6b1VvdVhVUGh5LV9xYllEaFJmeE9YdGI5U29kdUx6b3prWmJYd0haNHdjQU1TNmdrM2FJR2dQbWpiM0Z1UE5KbDc1Und6c1kxRmVZSzRHeWdoa3dValNoRnhkdXZndlRRYUd0RHZqcldtUmwyemt0NHBCRFFybjNXOUkxXzhBbjNtaHIySzBkNGx4LWNYQXNRTGkyVlFra0l5Z3JxLThiN0FDanBIcGhv?oc=5","date":"2022-01-19","type":"deal","source":"Fierce Pharma","summary":"UCB buys rare disease drugmaker Zogenix for up to $1.9B, bolstering its epilepsy position - Fierce Pharma","headline":"UCB buys rare disease drugmaker Zogenix for up to $1.9B, bolstering its epilepsy position","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxOVHlIOFdRZGstejFxQTA5OTM5UmZRdmVXRXZiT3VyTEYxQ2pFaE5xQTI3MmZxTkhPZWdqWVM2Y25URGZHVlBDZFo2WkRZdUxnSklta2ZvMjlsZVVvSWxUaVBLQW1SblppVVQxRkQwYlNNajJka1p4ZW1hc3V3V2ZOMklKdHdmeFJG?oc=5","date":"2022-01-19","type":"pipeline","source":"BioSpace","summary":"Global Roundup: UCB Snaps Up Rare Disease Company Zogenix - BioSpace","headline":"Global Roundup: UCB Snaps Up Rare Disease Company Zogenix","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxPV1FlU1pSY3dSNU9ZS2xhNEtyV08taC04TnFHYnAwM2ZfQWxRWS15YWlkLU9MT3hsTFpNREFfejY3U0trcnZac0xvRnFMTlhhbk9ELVBZeW5UcW9La2NZcGVOSWhxTklveGpwVFJDZEpLTVFmWVc3cnliZ09ZYktrQ1dXRE9hYWNKblo3WVZFTnpVZjRvNngtR29YZnc1QTN5cmxZc0FXcGJZVXVhb1JEa2ZPbnhHZkV4M1VZeEpURmZxOFl6YTEtREFIUQ?oc=5","date":"2022-01-19","type":"deal","source":"Reuters","summary":"Epilepsy drug maker Zogenix soars on UCB's potential $2 bln deal - Reuters","headline":"Epilepsy drug maker Zogenix soars on UCB's potential $2 bln deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxPNkNqa19QYXE5OXRMRThFdVVrSmVOT1l0Zlo1ank3UnVIbVNCWkZzLTRSRFJPaFY0QXFRME1xcXQtbm1pVU4tRENqRlpiR2RLZ184RWlfckRPMkowdlJ3TWItZ05KQlBwbkVPYlEzQWRtZThHVnB4R3hKYWpIQzl4dDRoSnd4b1pOeFBnZFNsajhSVUhGTnhvMDFzcUFtNlFlai1fY3pB?oc=5","date":"2022-01-19","type":"pipeline","source":"BioWorld News","summary":"UCB offers $1.9B for Zogenix and its rare epilepsy drug Fintepla - BioWorld News","headline":"UCB offers $1.9B for Zogenix and its rare epilepsy drug Fintepla","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxOQ3NxZkJPM3lWSGpOVXNnTG95Z01QVGU2OUcwQU5TNHRoal9sOVN0bDBYSUNzZndxRFFITlM4QnVQN2ViUmpFZkZYY2JFNHZlbkpVbi1oQW5ZcDAwallGcTBtN0JrRzlJbmVlbWlTZFJrQVQ3RVF2UVRaTzVneEEwWGU0WnhRNnhOVnBXcUlRR0FGZw?oc=5","date":"2021-01-26","type":"pipeline","source":"Clinical Leader","summary":"Zogenix Puts Focus On Safety In Seizure Patients - Clinical Leader","headline":"Zogenix Puts Focus On Safety In Seizure Patients","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-gFBVV95cUxPRWlrbXl3YU0tcGhyYm5TRjhNSHhPSXRTM1RZbTZFdVRxcTNJcFdRa0NUbmhENjNocHh1MEw1N1k2SW14aUpnN2czRjdYdWdhVkdERk9obTRSRFZBWHBIY25FZk44Y1RYSEtqdzhqU0R6NGItd1JPQ1N0a19jVmNBMG1uYlhmbTUzSUlIak5SelctMV9Qa2pKY0xRU3JDWV8xNEZsOGZZYjZRbEtxMUtRSno3OEttZU5uV0p6S0hKOTJINTItSXVhZTdobXRLdUtTWDBaYkVRamduU1V1YUpxMHJkWmV5T1U4VzlaZzVzWDdkdGt1WE9oUFpR?oc=5","date":"2019-03-19","type":"pipeline","source":"GlobeNewswire","summary":"Zogenix Enters Exclusive Distribution Agreement with Nippon Shinyaku for FINTEPLA® in Japan - GlobeNewswire","headline":"Zogenix Enters Exclusive Distribution Agreement with Nippon Shinyaku for FINTEPLA® in Japan","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxOZHNCa3BiZUhoQWJlY2FWR19zTDZBNWFUQnJsZjNIekxNZGt5N19RNDNFMVIzYmJtOXlOVVYxdS12bnMzYTNQZWpLZ09ybFdxckNMNUZkR3NZUjZZNHJJU3VOdmNZTGd6eDdSN09qcmFIbE1aMUFYeXRPb1VzMUZDQS1UQQ?oc=5","date":"2013-12-23","type":"pipeline","source":"Contract Pharma","summary":"Zogenix Expands Leadership Team - Contract Pharma","headline":"Zogenix Expands Leadership Team","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}